William Blair Starts PhaseBio Pharmaceuticals Inc. (PHAS) at Outperform
Get Alerts PHAS Hot Sheet
Price: $0.07 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
William Blair analyst Matt Phipps initiates coverage on PhaseBio Pharmaceuticals Inc. (NASDAQ: PHAS) with a Outperform rating.
For an analyst ratings summary and ratings history on PhaseBio Pharmaceuticals Inc. click here. For more ratings news on PhaseBio Pharmaceuticals Inc. click here.
Shares of PhaseBio Pharmaceuticals Inc. closed at $5.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts Solid Biosciences (SLDB) at Outperform, 'success in any of programs alone should provide severalfold upside from Solid’s current valuation'
- RBC Capital Starts Jasper Therapeutics (JSPR) at Outperform
- Guggenheim Starts ADC Therapeutics (ADCT) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!